Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03132987 · ClinicalTrials.gov registry record · NA
Characterizing Clinical and Biomechanical Contributions to Function Following ACL Reconstruction
A NA study, sponsored by Creighton University.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT03132987: Completed NA study, sponsored by Creighton University.
NCT03132987 is a NA study that has completed, run by Creighton University. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03132987, a NA study, has completed, sponsored by Creighton University.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
Quantify differences in quadriceps function and gait biomechanics in individuals within 2 years of ACL reconstruction compared to a healthy comparison group and establish the feasibility of conducting a progressive strengthening program to improve clinical and patient-oriented outcomes in individuals who are within 2 years of ACL reconstruction
Primary Outcome
slope of the torque-time tracing (change in torque/change in time) (Nm/kg\*s-1)
Interventions
- OTHER Progressive strengthening program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-07-31 |
| Phase | NA |
What the finished NCT03132987 record still lists
NCT03132987 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Progressive strengthening program is the first listed.
NCT03132987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03132987 about?
NCT03132987 is a clinical study titled "Characterizing Clinical and Biomechanical Contributions to Function Following ACL Reconstruction". Quantify differences in quadriceps function and gait biomechanics in individuals within 2 years of ACL reconstruction compared to a healthy comparison group and establish the feasibility of conducting a progressive strengthening program to improve clinical and patient-oriented outcomes in individual...
What is the current status of trial NCT03132987?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2017-01. Estimated completion is 2017-07-31.
What interventions are being tested in trial NCT03132987?
The interventions under investigation include: Progressive strengthening program (OTHER).
Who is sponsoring clinical trial NCT03132987?
This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03132987's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia